Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors

NCT01755182 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped difficulty enrollment, no patients received treatment

Conditions

Neuroendocrine Tumors

Interventions

DRUG: approved pharmacologic therapy
PROCEDURE: TAE

Sponsor

National Cancer Institute, Naples

Collaborators

[object Object]
[object Object]